CX3CR1 and glioblastoma: The stratification of glioblastoma multiforme (GBM) patients according to an MDM marker CD163 showed that the high CD163 level correlates with worse overall patient survival, whereas the level of microglial marker CX3CR1 showed no correlation [69].